After writing dozens of GLP-1 articles over the past year, one issue that consistently comes up is the affordability of ...

Weight-loss medicines like Semaglutide (GLP – 1RA), originally developed to help people with type 2 diabetes manage their ...

Hims & Hers Health, Inc. could see more upside in partnerships and international expansion. Click here to read an analysis of ...

NVO's new U.S. pricing deal for Ozempic and Wegovy expands access but adds uncertainty to its growth and profit outlook.

Zydus Lifesciences Ltd and Torrent Pharmaceuticals Ltd are preparing to enter the fast-growing market for Semaglutide — a ...

Eli Lilly (LLY) stock and Novo Nordisk (NVO) stock are in focus as the companies are nearing to strike U.S. pricing deals for ...

Direct-to-consumer (DTC) telehealth companies remove barriers to care, but questions remain regarding patient safety and proper information.

As you might expect, the competition to win a share of the expanding GLP-1 market is fierce right now, with giants Novo ...

Pennsylvanians deserve better than counterfeit medicine cooked up in back rooms and peddled through predatory online ads.

Novo Nordisk is under pressure from cheap copycats, a Trump pricing deal, and Lilly's fast-growing Zepbound juggernaut.

COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk trimmed its full-year forecasts on Wednesday as sales growth of its ...

How long would you need to jab yourself...and contend with the cost? Two MDs specializing in weight loss and endocrinology share how it works.